SARKANA PHARMA
Sarkana Pharma develops an anti-inflammatory biologic to treat certain types of auto-immune diseases.
SARKANA PHARMA
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2020-01-01
Status:
Active
Total Funding:
1.58 M USD
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
HebeCell
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Employees Featured
More informations about "Sarkana Pharma"
Sarkana Pharma - PitchBook
Sarkana Pharma General Information Description. Developer of an anti-inflammatory biologic drug intended to cure autoimmune diseases. The company is developing, to prove-of-concept, an …See details»
Sarkana Pharma, Inc. Company Profile - Dun & Bradstreet
Sarkana Pharma, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / MANUFACTURING / CHEMICAL MANUFACTURING / PHARMACEUTICAL AND MEDICINE …See details»
Sarkana Pharma Inc. - TVM Capital Life Science Venture …
Sarkana Pharma, Inc. plans to develop, to proof-of-concept, an anti-inflammatory biologic with the potential to treat certain types of auto-immune diseases, including systemic lupus erythematosus (SLE) also known as Lupus. It was …See details»
Sarkana Pharma - VentureRadar
Sarkana Pharma, Inc. plans to develop, to proof-of-concept, an anti-inflammatory biologic with the potential to treat certain types of auto-immune diseases, including systemic lupus …See details»
Sarkana Pharma - Products, Competitors, Financials, Employees ...
Sarkana Pharma plans to develop, to proof-of-concept, an anti-inflammatory biologic with the potential to treat certain types of auto-immune diseases, including systemic lupus …See details»
Sarkana Pharma - Funding, Financials, Valuation & Investors
Sarkana Pharma has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Seed round raised on Feb 16, 2021. Which funding types raised the most money? Show . …See details»
Sarkana Pharma - Crunchbase
Sarkana Pharma develops an anti-inflammatory biologic to treat certain types of auto-immune diseases.See details»
TVM Life Science Innovation II SCSp Announces Investment in …
Sarkana Pharma, Inc. plans to develop the antibody to a proof-of-concept study in systemic lupus erythematosus. The Lupus Foundation of America estimates that 1.5 million Americans, and at …See details»
Sarkana Pharma Stock Data, Filings, Earnings, News & Transcripts
Get the latest news, data and filings for Sarkana Pharma, with free alerts. Includes transcripts, social sentiment, and more.See details»
Sarkana Pharma - VentureRadar
Sarkana Pharma, Inc. plans to develop, to proof-of-concept, an anti-inflammatory biologic with the potential to treat certain types of auto-immune diseases, including systemic lupus …See details»
Sarkana Pharma Stock Price, Funding, Valuation, Revenue
See Sarkana Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on Sarkana Pharma's post-money valuation and revenue.See details»
Sarkana Pharma - Updates, News, Events, Signals & Triggers
Sarkana Pharma develops an anti-inflammatory biologic to treat certain types of auto-immune diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Clinical Trial on SRK-001 - Clinical Trials Registry - ICH GCP
Nov 16, 2021 March 9, 2023 updated by: Sarkana Pharma Inc. A Randomized, Placebo-Controlled, Double-blind, Multiple Dose, Phase 1 Study to Evaluate the Safety, Tolerability, …See details»
Sarkana Pharma, Inc. - fund raising filing - Form Ds
Feb 17, 2021 Sarkana Pharma, Inc. Industry: Pharmaceuticals (See others in industry) Address: 1000 N. West St., Suite 1200 Wilmington, DE, 19801 Phone: 6493324417 . Filings. Date Filing …See details»
Mark Cipriano Profile: Contact Information & Network - PitchBook
Co-Chief Executive Officer, Chief Financial Officer & Principal, Sarkana Pharma. Education. Suffolk University, BS (Bachelor of Science) Gender. Male. Phone +1 (649) Address. 1000 …See details»
Sarkana Pharma - Contacts, Employees, Board Members
Sarkana Pharma has 2 current employee profiles, including Co-Chief Executive Officer Caroline Fortier. Caroline Fortier Co-Chief Executive Officer. Juan Velasquez Co-Chief Executive …See details»
SRK-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Sarkana Pharma, Inc. NL-OMON52159 / Completed Not Applicable. A Randomized, Placebo-Controlled, Double-blind, Multiple Dose, Phase 1 Study to Evaluate the Safety, Tolerability, …See details»
LY-3200327 - Drug Targets, Indications, Patents - Synapse - Patsnap
Sarkana Pharma, Inc. NL-OMON52159 / Completed Not Applicable. A Randomized, Placebo-Controlled, Double-blind, Multiple Dose, Phase 1 Study to Evaluate the Safety, Tolerability, …See details»
Seed Round - Sarkana Pharma - 2021-02-16 - Crunchbase
Feb 16, 2021 Sarkana Pharma raised $1579000 on 2021-02-16 in Seed Round. Start Free TrialSee details»